Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of FibbroScan in Diagnosing MASLD Among the Chinese Population With Obesity

NCT06720766 is registered in ClinicalTrials.gov with The Third People's Hospital of Chengdu as lead sponsor.

NCT NCT06720766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06720766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of FibbroScan in Diagnosing MASLD Among the Chinese Population With Obesity
Lead sponsor
The Third People's Hospital of Chengdu
Phase
Observational
Overall status
Completed
Start date
October 24, 2023
Completion date
July 31, 2026
Enrollment
565 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fatty liver disease